- Home
- CLGN vs IHT Comparison
CLGN vs IHT Comparison
Compare CLGN & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- IHT
- Stock Information
- Founded
- CLGN 2004
- IHT 1971
- Country
- CLGN Israel
- IHT United States
- Employees
- CLGN N/A
- IHT N/A
- Industry
- CLGN Industrial Specialties
- IHT Investment Bankers/Brokers/Service
- Sector
- CLGN Health Care
- IHT Finance
- Exchange
- CLGN Nasdaq
- IHT Nasdaq
- Market Cap
- CLGN 19.1M
- IHT 20.2M
- IPO Year
- CLGN N/A
- IHT N/A
- Fundamental
- Price
- CLGN $1.37
- IHT $2.20
- Analyst Decision
- CLGN Strong Buy
- IHT
- Analyst Count
- CLGN 2
- IHT 0
- Target Price
- CLGN $11.50
- IHT N/A
- AVG Volume (30 Days)
- CLGN 127.7K
- IHT 1.4K
- Earning Date
- CLGN 08-19-2025
- IHT 07-11-2025
- Dividend Yield
- CLGN N/A
- IHT 0.91%
- EPS Growth
- CLGN N/A
- IHT N/A
- EPS
- CLGN N/A
- IHT N/A
- Revenue
- CLGN $2,472,000.00
- IHT $7,505,309.00
- Revenue This Year
- CLGN $2,177.67
- IHT N/A
- Revenue Next Year
- CLGN $56.52
- IHT N/A
- P/E Ratio
- CLGN N/A
- IHT N/A
- Revenue Growth
- CLGN N/A
- IHT N/A
- 52 Week Low
- CLGN $1.31
- IHT $1.34
- 52 Week High
- CLGN $5.48
- IHT $2.70
- Technical
- Relative Strength Index (RSI)
- CLGN 39.49
- IHT 37.75
- Support Level
- CLGN $1.35
- IHT $2.20
- Resistance Level
- CLGN $1.54
- IHT $2.35
- Average True Range (ATR)
- CLGN 0.14
- IHT 0.07
- MACD
- CLGN -0.02
- IHT -0.00
- Stochastic Oscillator
- CLGN 2.88
- IHT 21.05
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.